Breaking News Instant updates and real-time market news.

JPM

JPMorgan

$107.36

-2.23 (-2.03%)

, ORCL

Oracle

$48.84

-0.68 (-1.37%)

16:20
11/14/18
11/14
16:20
11/14/18
16:20

Berkshire Hathaway adds to Apple, takes JPMorgan stake in Q3

Warren Buffett's Berkshire Hathaway disclosed in an SEC filing its holdings as of September 30, 2018. Berkshire Hathaway's four new buys during the third quarter were, by size of position, JPMorgan Chase (JPM), Oracle (ORCL), PNC Financial (PNC), Travelers Companies (TRV). Berkshire Hathaway exited two positions during the quarter, which were, by size of previous position, Sanofi (SNY) and Walmart (WMT). Berkshire Hathaway increased its stake in seven holdings, including by size of previous position, Apple (AAPL), Bank of America (BAC), US Bancorp (USB), Goldman Sachs (GS), and Delta (DAL). Berkshire Hathaway reduced its stake in six holdings, including by size of previous position, Phillips 66 (PSX), Wells Fargo (WFC), American Airlines (AAL), Charter (CHTR), and United Continental (UAL). Berkshire Hathaway's top holdings as of September 30, 2018, in order of size, were Apple, Bank of America, Wells Fargo, Coca-Cola (KO), and Kraft Heinz (KHC).

JPM

JPMorgan

$107.36

-2.23 (-2.03%)

ORCL

Oracle

$48.84

-0.68 (-1.37%)

PNC

PNC Financial

$134.22

-1.495 (-1.10%)

TRV

Travelers

$123.01

-3.82 (-3.01%)

SNY

Sanofi

$45.08

0.18 (0.40%)

WMT

Walmart

$101.58

-1.37 (-1.33%)

AAPL

Apple

$186.81

-5.42 (-2.82%)

BAC

Bank of America

$27.23

-0.53 (-1.91%)

USB

U.S. Bancorp

$54.01

0.32 (0.60%)

GS

Goldman Sachs

$202.43

-2.49 (-1.22%)

DAL

Delta Air Lines

$56.43

-0.38 (-0.67%)

PSX

Phillips 66

$95.59

0.78 (0.82%)

WFC

Wells Fargo

$52.15

-0.59 (-1.12%)

AAL

American Airlines

$38.10

0.32 (0.85%)

CHTR

Charter

$320.65

-4.01 (-1.24%)

UAL

United Continental

$91.79

-0.81 (-0.87%)

KO

Coca-Cola

$49.77

-0.09 (-0.18%)

KHC

Kraft Heinz

$52.63

-0.75 (-1.41%)

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

  • 16

    Jan

  • 28

    Jan

  • 12

    Feb

  • 26

    Feb

  • 03

    Mar

  • 11

    Mar

  • 22

    Mar

  • 12

    Apr

  • 12

    Apr

  • 28

    Apr

  • 13

    Jul

  • 17

    Jul

  • 12

    Oct

  • 16

    Oct

JPM JPMorgan
$107.36

-2.23 (-2.03%)

10/16/18
JANY
10/16/18
NO CHANGE
JANY
Buy
Janney Montgomery Scott says On Deck's new unit hints at new bank partnerships
After On Deck Capital (ONDK) announced earlier that it has created a new wholly owned subsidiary, ODX, that will provide technology and other services to banks looking to lend online to small businesses, Janney Montgomery Scott analyst John Rowan said he sees this as the logical step before the company announces one or more new bank partnerships. While he thinks the company's lone existing bank partnership, with JPMorgan (JPM), is not a profit center, Rowan believes that the economics could improve as each new bank partner comes on-board and he thinks ODX could eventually become a profit center for On Deck. He maintains a Buy rating on the stock.
10/15/18
BMOC
10/15/18
NO CHANGE
Target $124
BMOC
Market Perform
JPMorgan price target raised to $124 from $118 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on JPMorgan to $124 after its Q3 earnings beat driven by lower than expected loan loss provision. The analyst notes that financials are "cheap again" in spite of the rising interest rates which are positive for net interest margins, better employment which is positive for credit, and regulatory relief which is positive for their capital position. Fotherinham also keeps his Market Perform rating on JPMorgan, saying its two-year forward earnings multiple is "only slightly" below its long-term historical average.
09/25/18
WOLF
09/25/18
INITIATION
Target $140
WOLF
Outperform
JPMorgan initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated JPMorgan with an Outperform and $140 price target.
10/03/18
BERN
10/03/18
NO CHANGE
BERN
Amazon to be accelerant of disruption coming for healthcare, says Bernstein
Bernstein analyst Lance Wilkes believes disruption is coming for healthcare and that Amazon (AMZN) will be an accelerant of this disruption. Further, the analyst sees a parallel with the fast changes in health insurance which took place in the 90's, when health insurance changed from 90% indemnity to 80% managed care within ten years. Wilkes thinks Amazon is developing a series of business strategies for entering healthcare market segments, namely directly entering online pharmacy, creating a disruptor in the employer healthcare space through its venture with Berkshire (BRK.A) and JPMorgan (JPM), and entering digital consumer healthcare spaces including using Alexa for consumer engagement and behavior modification.
ORCL Oracle
$48.84

-0.68 (-1.37%)

10/29/18
STFL
10/29/18
DOWNGRADE
Target $190
STFL
Hold
Stifel downgrades Red Hat to Hold, but sees potential for competing bid
Stifel analyst Brad Reback downgraded Red Hat (RHT) to Hold from Buy after IBM (IBM) announced an agreement to acquire the company for $190 per share. Stating that he is not aware of any M&A talks, Reback added that he would not be surprised if a hyperscale cloud vendor such as Google (GOOGL), Amazon (AMZN), Microsoft (MSFT) or Oracle (ORCL) to make a competing bid given Red Hat's strategic position within on-premise datacenters. Reback raised his price target on Red Hat shares from $160 to the announced deal price of $190.
10/23/18
NEED
10/23/18
INITIATION
NEED
Hold
Oracle initiated with a Hold at Needham
As reported earlier, Needham analyst Jack Andrews initiated Oracle with a Hold rating as part of his broader infrastructure software research note. The analyst notes that he is positive on the company's "potential and resources to become a significant force in next generation cloud computing environments," but prefers to await a "more consistent record of quarterly financial results meeting guidance" before taking a more constructive stance.
11/06/18
JMPS
11/06/18
INITIATION
Target $29
JMPS
Outperform
Anaplan initiated with an Outperform at JMP Securities
JMP Securities analyst Patrick Walravens initiated Anaplan (PLAN) with an Outperform rating and $29 price target, stating that he believes it is well-positioned to increase its share of the worldwide performance management and analytic applications software market from about 1% today to about 3% in 2022. He sees the company being able to take share from Excel-based solutions, homegrown products, and incumbents such as Oracle (ORCL), IBM (IBM), and SAP (SAP), Walravens added.
10/26/18
NOMU
10/26/18
NO CHANGE
Target $53
NOMU
Buy
Oracle price target lowered to $53 from $58 at Nomura Instinet
Nomura Instinet analyst Christopher Eberle lowered his price target for Oracle to $53 and keeps a Buy rating on the shares following the company's Open World convention and analyst day. The analyst says that while he appreciates the use of case performance scenarios highlighted by management throughout the week, the investment community has grown frustrated with the "sizable disconnect between management's sanguine commentary and another year of little to zero top-line growth."
PNC PNC Financial
$134.22

-1.495 (-1.10%)

11/06/18
PIPR
11/06/18
NO CHANGE
Target $163
PIPR
Overweight
PNC Financial well positioned for regulatory relief, says Piper Jaffray
Piper Jaffray analyst Kevin Barker maintains an Overweight rating on PNC Financial and raised his price target for the shares to $163 from $159 to take into account the capital relief he expects from the Federal Reserve's recently proposed rules. The analyst is also more bullish on PNC's revenue outlook, saying the company is seeing a significant increase in treasury management fees due to a decline in commercial non-interest bearing deposits. The market's sole focus on the shift to interest-bearing deposits from non-interest bearing deposits fails to take into account the offsetting revenue, Barker tells investors in a research note. He calls PNC one of his favorite super-regional banks at this point in the cycle.
10/15/18
10/15/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McDonald's (MCD) upgraded to Outperform from In Line at Evercore ISI with analyst Matt McGinley citing lowered expectations on comps, a pullback in valuation relative to last year, and the more defensive nature of the business model. 2. PNC Financial (PNC) upgraded to Outperform from Market Perform at Bernstein and to Buy from Hold at Deutsche Bank. 3. Ralph Lauren (RL) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss saying the recent pullback in the shares creates a "multi-year opportunity." 4. Activision Blizzard (ATVI) upgraded to Overweight from Equal Weight at Barclays with analyst Ryan Gee saying his positive view is based on upside potential for Call of Duty digital revenue in 2019 from battle royale, as well as optimism for incremental product announcements at BlizzCon "fueling positive revisions" to consensus 2019 earnings estimates. 5. Lululemon (LULU) upgraded to Outperform from Neutral at Wedbush with analyst Jen Redding saying she has long viewed lululemon as an "impressive" growth story, with a best-in-class retail leadership team at the helm, and continues to see the company's cutting-edge data analytics and technology platforms on the forefront of wins in the years to come. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/15/18
BMOC
10/15/18
NO CHANGE
Target $139
BMOC
Outperform
PNC Financial price target lowered to $139 from $156 at BMO Capital
BMO Capital analyst Lana Chan lowered her price target on PNC Financial to $139 to reflect the 6% decline in its stock price from the bank's "low-quality" Q3 EPS beat, but also sees it as an "over-reaction" given its solid pre-provision net revenue growth. The analyst further attributes the price target change to a "more conservative multiple" from the bank's late-cycle valuation but also keeps her Outperform rating. Chan notes that the new implied valuation puts PNC in line with its peers even though its profile of positive operating leverage, greater capital return, and insulation from any potential downturn deserves a premium.
10/31/18
MSCO
10/31/18
NO CHANGE
MSCO
Morgan Stanley sees BB&T, AmEx as possible winners if Fed changes bank rules
Noting that the Federal Reserve will release a memo detailing proposed changes to bank capital rules to the public around 10 am today and is scheduled to vote on this proposal in a meeting starting at 10:30 am, Morgan Stanley analyst Betsy Graseck said BB&T (BBT) could be the biggest beneficiary with a 5% EPS increase if it is ruled that banks with more than $250B in assets that are not Global Systemically Important Banks should have more tailored regulation. Other potential beneficiaries of possible rule changes include American Express (AXP), Capital One (COF), Northern Trust (NTRS), PNC Financial (PNC) and U.S. Bancorp (USB), Graseck added.
TRV Travelers
$123.01

-3.82 (-3.01%)

07/24/18
MKMP
07/24/18
NO CHANGE
Target $125
MKMP
Neutral
Travelers price target lowered to $125 from $140 at MKM Partners
MKM Partners analyst Harry Fong lowered his price target on Travelers to $125 after its Q2 earnings miss, saying the quarter was impacted by "several large commercial losses, chiefly from fire losses and an assessment from the Texas windstorm pool related to Hurricane Harvey". The analyst notes that the sell off in the stock was somewhat surprising, since the earnings miss was due to "normal insurance noise" that is typical for the industry. Fong also keeps his Neutral rating on Travelers which he attributes to 1.4-times trailing book value multiple, rather than its recent earnings proposal.
10/19/18
SBSH
10/19/18
DOWNGRADE
SBSH
Neutral
Citi downgrades Travelers to Neutral with 'several' risks emerging
Citi analyst James Naklicki downgraded Travelers to Neutral from Buy and lowered his price target for the shares to $134 from $149. There are several emerging risks for Travelers that don't appear priced into the stock, Naklicki tells investors in a research note. The company's strategy has shifted from one of accelerating commercial pricing to one of moderating pricing this quarter, the analyst says. And with its margins down year-to-date, he thinks Travelers "should continue to take rate," which he finds disappointing. Further, Naklicki sees "new risks are on the horizon" from rising inflation expectations and rising loss trends in workers comp.
10/19/18
SBSH
10/19/18
DOWNGRADE
Target $134
SBSH
Neutral
Travelers downgraded to Neutral from Buy at Citi
Citi analyst James Naklicki downgraded Travelers to Neutral and lowered his price target for the shares to $134 from $149 following yesterday's Q3 results.
08/07/18
FBCO
08/07/18
INITIATION
Target $141
FBCO
Neutral
Travelers initiated with a Neutral at Credit Suisse
Credit Suisse analyst Michael Zaremski started Travelers (TRV) with a Neutral rating and $141 price target. For shorter-term oriented investors, the analyst recommends Travelers over peer Chubb (CB) due to having more conviction over its recent string of higher than expected non-catastrophe weather-related losses subsiding, a greater gearing to workers' comp. leading to a steady stream of reserve releases given an extremely healthy unemployment backdrop, and conviction that near-term auto margins will continue to improve given industry pricing dynamics. In the longer term, he struggles to make the case that Travelers' wheels business can produce better and less volatile results.
SNY Sanofi
$45.08

0.18 (0.40%)

11/01/18
11/01/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nutrisystem (NTRI) upgraded to Outperform from Market Perform at Barrington and to Neutral from Underperform at DA Davidson. 2. SeaWorld (SEAS) upgraded to Overweight from Sector Weight at KeyBanc with analyst Brett Andress saying de-risked expectations following the Q3 pre-announcement create an attractive entry point, as he sees further upside to shares, with his confidence in the company's turnaround bolstered by additional evidence of both a brand and business in recovery mode. 3. Sanofi (SNY) upgraded to Equal Weight from Underweight at Barclays with analyst Emmanuel Papadakis saying he sees a more balanced risk/reward profile at current share levels. 4. Asur (ASR) upgraded to Overweight from Neutral at JPMorgan with analyst Fernando Abdalla citing valuation. 5. Wex (WEX) upgraded to Outperform from Market Perform at Wells Fargo. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/23/18
WOLF
10/23/18
INITIATION
WOLF
Peer Perform
Sanofi reinitiated with a Peer Perform at Wolfe Research
10/25/18
WELS
10/25/18
NO CHANGE
WELS
Wells Fargo says Trump speech today won't be end of drug pricing proposals
Wells Fargo analyst David Maris notes that Politico and other media outlets are reporting that President Donald Trump will propose several new initiatives to address high drug prices when he speaks later today at the U.S. Department of Health and Human Services. Maris thinks Trump's focus will be on how other countries are "freeloading" on U.S. innovation with lower negotiated pricing, stating that news reports make it appear that the administration is targeting the industry for action, rather than other countries to raise their spending. While Maris acknowledges the timing of the speech being near the mid-term elections, he believes these proposals are simply the follow-though of earlier promises. He also expects this is not the end of proposals to address the issue of U.S. drug pricing. Publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
11/01/18
LEHM
11/01/18
UPGRADE
LEHM
Equal Weight
Sanofi upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Emmanuel Papadakis upgraded Sanofi to Equal Weight and raised his price target for the shares to EUR 80 from EUR 68 following the company's Q3 results. The analyst sees a more balanced risk/reward profile at current share levels.
WMT Walmart
$101.58

-1.37 (-1.33%)

11/08/18
BARD
11/08/18
NO CHANGE
Target $110
BARD
Outperform
Walmart headed for 'solid Q3 results' says Baird
Baird analyst Peter Benedict kept his Outperform rating and $110 price target on Walmart ahead of its Q3 results, saying he has an upward bias to its U.S. comps expectations after the management's "bullish" tone at last month's investor meeting. The analyst adds that the prospects for sustained momentum also appear to be good given the "multiple in-store and online initiatives converging" and the backdrop for consumer spending remaining firm.
11/02/18
SPHN
11/02/18
DOWNGRADE
Target $26
SPHN
Underweight
Synchrony downgraded to Underweight from Equal Weight at Stephens
Stephens analyst Vincent Caintic downgraded Synchrony (SYF) to Underweight from Equal Weight, citing the negative implications he sees from the lawsuit against the company from Walmart (WMT). Beyond the potential for over $800M in damages, the suit implies the Sam's Club account is lost, the Amazon (AMZN) account is "in jeopardy," and other retailers can be expected to "take a hard look" at their own relationships with Synchrony, Caintic believes. He lowered his price target on Synchrony shares to $26 from $32.
10/29/18
COWN
10/29/18
NO CHANGE
Target $120
COWN
Walmart price target raised to $120 from $115 at Cowen
Cowen analyst Oliver Chen raised his price target on Walmart to $120 from $115 following his meeting with management. The analyst said the company is well positioned in the retail race, citing its rapid acquisition of new brands combined with increasing same-day deliveries and a fresh food supply chain. Chen reiterated his Outperform rating on Walmart shares.
10/22/18
MKMP
10/22/18
NO CHANGE
Target $105
MKMP
Neutral
Walmart price target lowered to $105 at MKM Partners after analyst meeting
MKM Partners analyst Patrick McKeever nudged his price target on Walmart lower to $105 from $107 and also kept his Neutral rating after its annual meeting with the investment community, saying he has turned "more positive" on the outlook for the company's top line. The analyst cites Walmart's continued benefits coming from a "very favorable consumer backdrop, better store execution driven by wage/training investments, aggressive adaption of new technology, an improved fresh assortment, and strong momentum in e-commerce." McKeever anticipates more challenges for Walmart's profitability however because of wider e-commerce losses than anticipated in addition to incremental pressures coming from the fuel/transport costs and retail price investment.
AAPL Apple
$186.81

-5.42 (-2.82%)

11/14/18
ADAM
11/14/18
NO CHANGE
Target $83
ADAM
Buy
Qorvo price target lowered to $83 from $90 at Canaccord
Canaccord analyst T. Michael Walkley lowered his price target on Qorvo (QRVO) to $83 from $90 after the company lowered its guidance, as several Apple (AAPL) suppliers have done. He expects Qorvo to continue focusing on developing integrated solutions to drive dollar content growth faster than the slow growing smartphone market and anticipates improving growth trends as 5G ramps long-term. Walkley reiterated his Buy rating on Qorvo shares.
11/14/18
11/14/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Neutral from Buy at Guggenheim with analyst Robert Cihra saying the average selling price of the iPhone has increased a "dramatic" $220, or 40%, over the past 10 years, reflecting its "growing value to both consumer and business markets." 2. Kellogg (K) downgraded to Neutral from Overweight at JPMorgan with analyst Ken Goldman saying that while nothing at the company's investor day "necessarily disappointed" him, he also did not gain "much comfort that the bottom-line turnaround would be swift." 3. Apollo Global (APO) and Carlyle Group (CG) were downgraded to Equal Weight from Overweight at Morgan Stanley. 4. Conagra Brands (CAG) downgraded to Underperform from Market Perform at Bernstein with analyst Alexia Howard saying the frozen category has experienced positive growth over the past year, largely led by new product innovation from Conagra and Pinnacle Foods, but this now seems to be running out of steam. 5. Tenneco (TEN) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Armintas Sinkevicius citing its elevated leverage and limited free cash flow conversion in what he views as an increasingly uncertain environment for auto suppliers. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/18
DADA
11/14/18
NO CHANGE
Target $72
DADA
Neutral
Qorvo price target lowered to $72 from $81 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Qorvo (QRVO) to $72 and kept his Neutral rating after the company cut its Q3 earnings guidance to reflect the expectations of a weaker high-end smartphone demand. The analyst believes that the "softer than expected" launch of the new iPhones by Apple (AAPL) has " triggered a rapid change in order flow over the past couple of weeks" and anticipates similar announcements from other Apple suppliers to track reduced guidance by Qorvo and Lumentum (LITE).
11/14/18
LOOP
11/14/18
NO CHANGE
Target $85
LOOP
Buy
Qorvo price target lowered to $85 from $90 at Loop Capital
Loop Capital analyst Cody Acree lowered his price target on Qorvo (QRVO) to $85 after its reduced Q3 guidance, saying the "softer unit volumes" sold by Apple (AAPL) were "undoubtedly the primary unnamed specific cause". The analyst is keeping his Buy rating on the shares however, stating that the "tier-1 smartphone unit weakness is becoming a common theme" that is generating lesser impact with each news release as evidenced by Qorvo's shares trading flat yesterday. Acree adds that investors should start to "pick their spots for 2019" amid the smartphone industry's start of migration to 5G and believes that Qorvo is "well positioned to continue to gain share at the leading tier-1 handset OEMs".
BAC Bank of America
$27.23

-0.53 (-1.91%)

07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.
07/17/18
BARD
07/17/18
NO CHANGE
Target $30
BARD
Neutral
Baird would be buyers of Bank of America on weakness
Baird analyst David George said he would remain a buyer of Bank of America shares on any weakness, stating that its operating leverage was impressive in Q2 and should continue along with solid execution. George maintained his Neutral rating and $30 price target on Bank of America shares.
09/19/18
OPCO
09/19/18
NO CHANGE
OPCO
Outperform
U.S. banks 'in very good shape,' says Oppenheimer, favorites include BofA, Citi
Oppenheimer analyst Chris Kotowski tells investors in a research note that the U.S. banking group is on solid footing with balance sheets less risky than at any time over the last 33 years the firm covered the group and says his favorite bank stocks are Outperform-rated Bank of America (BAC), Citi (C), CIT (CIT) and Goldman Sachs (GS). However, Kotowski notes that banks are trading at an average relative P/E of just ~66% relative to the S&P 500 and returning to a historical avg valuation of 73%-80% range would imply over a thousand basis points of outperformance by the group. In his view, the U.S. banks are, on the whole, in "very good" shape.
09/25/18
WOLF
09/25/18
INITIATION
Target $40
WOLF
Outperform
Bank of America initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Bank of America with an Outperform and $40 price target.
USB U.S. Bancorp
$54.01

0.32 (0.60%)

10/18/18
OPCO
10/18/18
UPGRADE
OPCO
Outperform
U.S. Bancorp upgraded to Outperform from Perform at Oppenheimer
10/18/18
10/18/18
UPGRADE
Target $62

Outperform
U.S.Bancorp upgraded to Outperform on positive operating leverage at Oppenheimer
As previously reported, Oppenheimer analyst Chris Kotowski upgraded U.S. Bancorp to Outperform from Perform, with a $62 price target. The analyst notes that since rates started rising in late 2015, USB has started seeing accelerating core earnings growth again, but the growth rate has slightly lagged behind peers' as a result of modestly negative operating leverage. Q3 brought the second consecutive quarter of positive operating leverage, and he thinks U.S. Bancorp is now well poised to outperform.
11/02/18
SBSH
11/02/18
DOWNGRADE
SBSH
Neutral
U.S. Bancorp downgraded to Neutral from Buy at Citi
Citi analyst Keith Horowitz downgraded U.S. Bancorp to Neutral.
GS Goldman Sachs
$202.43

-2.49 (-1.22%)

10/17/18
BMOC
10/17/18
NO CHANGE
Target $276
BMOC
Market Perform
Goldman Sachs price target raised to $276 from $261 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Goldman Sachs to $276 after its Q3 earnings beat, with results featuring higher than expected investment banking fees and a "strong showing" from its incoming CFO Stephen Scherr. The analyst notes that financials are "cheap again" in spite of the rising short-term rates, improving employment, and continued regulatory relief. Fotheringham also keeps his Market Perform rating on Goldman Sachs on valuation, noting that its two-year foward PE multiple is "only slightly" below its long-term historical average.
10/16/18
JMPS
10/16/18
NO CHANGE
JMPS
Market Perform
JMP Securities sees Goldman Sachs Q3 results as 'solid'
JMP Securities analyst Devin Ryan says Goldman Sachs Q3 results were "solid,' in aggregate, against a seasonally slow backdrop. Nonetheless, the analyst suspects the Street could pick a bit at several items, such as the lower tax rate, lower comp ratio, or modest underperformance in FICC trading. Taking a step back, Ryan believes the market should be encouraged by the 13% return on equity. He reiterates a Market Perform rating on the shares.
09/25/18
WOLF
09/25/18
INITIATION
Target $290
WOLF
Outperform
Goldman Sachs initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Goldman Sachs with an Outperform and $290 price target.
DAL Delta Air Lines
$56.43

-0.38 (-0.67%)

11/12/18
GSCO
11/12/18
INITIATION
Target $64
GSCO
Neutral
Delta Air Lines initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Catherine O'Brien started Delta Air Lines with a Neutral rating and $64 price target. The analyst sees lower margin improvement at the company relative to other airlines. She also launched coverage on the U.S. Airlines sector with an Attractive coverage view. Stronger revenue trends in 2019 coupled with a focus on cost control should drive higher industry operating margins for the first time since 2015 despite fuel headwinds, O'Brien tells investors in a research note.
10/15/18
WBLR
10/15/18
NO CHANGE
WBLR
Market Perform
Delta CEO comments positive data point for Gogo, says William Blair
William Blair analyst Louie DiPalma points out that Delta Air Lines (DAL) CEO Ed Bastian said a few weeks ago at the Skift Global Forum that Gogo (GOGO) has "really stepped up to the plate." The full interview was posted on YouTube just last week. An endorsement from the CEO of the largest airline in the world by revenue is a positive data point for Gogo, DiPalma tells investors in a research note. The analyst finds the commentary especially noteworthy given Gogo's recent service issues and as it evaluates strategic alternatives. Shares of Gogo are up 5%, or 27c, to $5.77 in afternoon trading. DiPalma has a Market Perform rating on the name. Reference Link
10/17/18
DBAB
10/17/18
UPGRADE
Target $60
DBAB
Buy
Delta Air Lines upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Michael Linenberg upgraded Delta Air Lines to Buy and raised his price target for the shares to $60 from $53. The analyst cites the company's better than expected fuel expense for the upgrade.
10/17/18
10/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Infosys (INFY) upgraded to Market Perform from Underperform at William Blair WITH analyst Maggie Nolan citing Q2 results. 2. American Airlines (AAL), Delta Air Lines (DAL), and United Continental (UAL) upgraded to Buy from Hold at Deutsche Bank. 3. Akorn (AKRX) upgraded to Overweight from Neutral at Piper Jaffray with analyst David Amsellem saying based on trends associated with a number of its notable products, as well as his recent conversation with management, he believes a picture of sustainable EBITDA is emerging at Akorn that is better than what he had previously envisioned. 4. Workday (WDAY) upgraded to Outperform from Market Perform at Bernstein with analyst Mark Moerdler saying he determined that even if the ERP market moves reasonably slowly to the Cloud, it is large enough and the fact there are only a few vendors with a competitive SaaS solution should allow Workday to continue to gain share. 5. Domino's Pizza (DPZ) upgraded to Buy from Hold at Maxim with analyst Stephen Anderson saying the pullback in the stock price is overdone and expects accelerated cost savings and solid comps to yield higher earnings, raising his FY20 EPS view to $12.01 from $11.72. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
PSX Phillips 66
$95.59

0.78 (0.82%)

10/16/18
JEFF
10/16/18
UPGRADE
Target $108
JEFF
Hold
Phillips 66 upgraded to Hold from Underperform at Jefferies
Jefferies analyst Christopher Sighinolfi upgraded Phillips 66 to Hold and raised his price target for the shares to $108 from $90.
10/03/18
LEHM
10/03/18
NO CHANGE
LEHM
Barclays upgrades Phillips 66, downgrades CVR Refining to Underweight
Barclays analyst Paul Cheng upgrades Phillips 66 (PSX) to Equal Weight from Underweight while lowering his price target for the shares to $128 from $133. The analyst cites valuation for the upgrade, noting the stock is up 13% year-to-date while peers are up 30%. Cheng coupled the upgrade with a downgrade of CVR Refining (CVRR) to Underweight from Equal Weight. The analyst also cut his price target for the shares to $20 from $24. Earlier this year, CVR Energy (CVI) purchased a number of CVR Refining units and the parent plus affiliates now own around 85% of the partnership, Cheng tells investors in a research note. According to the partnership agreement, once the general partner and affiliates own more than 80% of CVR Refining common units, CVR Energy can call the remaining units at the higher of the market price or the last 20 days' moving average, the analyst adds. As such, he sees little reason to own CVR Refining specifically, saying the call provision "essentially eliminates any upside to the units."
10/30/18
JPMS
10/30/18
UPGRADE
Target $138
JPMS
Overweight
Phillips 66 upgraded to Overweight on 'compelling' valuation at JPMorgan
JPMorgan analyst Phil Gresh upgraded Phillips 66 to Overweight from Neutral with an unchanged price target of $138. The analyst sees 44% total return potential by December 2019. Following the recent pullback in the shares, Phillips 66's valuation "looks increasingly compelling," Gresh tells investors in a research note. The company has the diversification benefits of the majors, without the Upstream oil price volatility, the analyst contends. Further, he sees IMO 2020 benefiting the refiners.
10/30/18
JPMS
10/30/18
UPGRADE
Target $138
JPMS
Overweight
Phillips 66 upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Phil Gresh upgraded Phillips 66 to Overweight with a $138 price target.
WFC Wells Fargo
$52.15

-0.59 (-1.12%)

11/02/18
SBSH
11/02/18
UPGRADE
SBSH
Buy
Wells Fargo upgraded to Buy from Neutral at Citi
Citi analyst Keith Horowitz upgraded Wells Fargo to Buy.
10/15/18
BMOC
10/15/18
NO CHANGE
Target $65
BMOC
Market Perform
Wells Fargo price target raised to $65 from $61 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Wells Fargo to $65 in spite of its Q3 revenue miss as he raises his FY19 EPS view by 1c to $5.23 to reflect lower expected credit costs. The analyst also notes that financials are "cheap again" in spite of the rising interest rates which are positive for net interest margins, better employment which is positive for credit, and regulatory relief which is positive for their capital position. Fotheringham also keeps his Market Perform rating on Wells Fargo, saying that while the bank's valuation is getting "cheap" for the first time since he launched coverage, better opportunities exist in other large-cap financials.
10/15/18
10/15/18
UPGRADE
Target $62

Outperform
Wells Fargo upgraded to Outperform, visibility improving, says Macquarie
As previously reported, Macquarie upgraded Wells Fargo to Outperform from neutral with a $62 price target. Analyst David Konrad said Wells Fargo shares are trading at a 10% discount to peers and believes investors will warm up to the company's self-help story of meaningful expense savings over the next two years combined with better than peer buybacks. Konrad notes revenue growth will be challenging, but is encouraged by signs from consumers in the form of improved checking account and card growth, and moderating FA turnover.
10/15/18
MACQ
10/15/18
UPGRADE
MACQ
Outperform
Wells Fargo upgraded to Outperform from Neutral at Macquarie
AAL American Airlines
$38.10

0.32 (0.85%)

10/30/18
JPMS
10/30/18
NO CHANGE
Target $46
JPMS
Overweight
American Airlines added to Analyst Focus List at JPMorgan
JPMorgan analyst Jamie Baker added American Airlines to his firm's Analyst Focus List. Baker this morning lowered his price target for the shares to $46 from $53 and kept an Overweight rating on the name.
11/12/18
GSCO
11/12/18
INITIATION
Target $44
GSCO
Buy
American Airlines initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Catherine O'Brien started American Airlines with a Buy rating and $44 price target. The analyst expects "idiosyncratic opportunities" to drive higher controllable earnings than the industry average. She also launched coverage on the U.S. Airlines sector with an Attractive coverage view. Stronger revenue trends in 2019 coupled with a focus on cost control should drive higher industry operating margins for the first time since 2015 despite fuel headwinds, O'Brien tells investors in a research note.
10/17/18
DBAB
10/17/18
UPGRADE
Target $47
DBAB
Buy
American Airlines upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Michael Linenberg upgraded American Airlines Group to Buy and raised his price target for the shares to $47 from $40. The analyst cites the company's better than expected fuel expense for the upgrade.
CHTR Charter
$320.65

-4.01 (-1.24%)

08/02/18
RILY
08/02/18
NO CHANGE
Target $62
RILY
Buy
GCI Liberty price target lowered to $62 from $70 at B. Riley FBR
B. Riley FBR analyst Barton Crockett lowered his price target for GCI Liberty (GLIBA) to $62 after updating his sum-of-the-parts analysis. The analyst still sees potential upside of 30%-plus, likely realized over next couple years via a merger with Charter Communications (CHTR). Charter is likely interested in GCI Liberty because of its holdings of Charter-related equity and its Alaskan cable business, Crockett tells investors in a research note. He keeps a Buy rating on GCI.
10/23/18
GUGG
10/23/18
INITIATION
Target $400
GUGG
Buy
Charter assumed with a Buy at Guggenheim
Guggenheim analyst Mike McCormack assumed coverage of Charter Communications with a Buy rating and $400 price target.
10/29/18
RHCO
10/29/18
NO CHANGE
Target $365
RHCO
Buy
Charter price target lowered to $365 from $390 at SunTrust
SunTrust analyst Greg Miller lowered his price target on Charter to $365 after its Q3 results showed both revenue and EBITDA falling short of his expectations. The analyst also keeps his Buy rating on Charter, noting that while the company's other "key performance indicators were similarly below expectations", its "bigger picture trends" were "consistent and encouraging". Miller forecasts the company to see more cash flow tailwinds from growing broadband customer base and declining capital intensity.
10/23/18
10/23/18
NO CHANGE

Guggenheim assumes select Cable/Satellite names with positive outlook
Guggenheim analyst Mike McCormack assumed coverage of select Cable & Satellite Services companies with a positive outlook, saying that while each company is facing "video headwinds", they also offer shared catalysts of "the demand for broadband connectivity, increasingly faster speeds, and new wireless products". The analyst assumes Altice USA (ATUS), Charter (CHTR) and Dish (DISH) with Buy ratings and Comcast (CMCSA) with a Neutral rating, adding that its "business is in transition" with core risks around domestic and international operations. McCormack puts a $23 price target on Altice USA, $400 price target on Charter, $38 price target on Comcast, and a $50 price target on Dish, adding that the "importance of the bundle is diminishing" and the focus shifts to the scope of connectivity coverage. The analyst also expects the "younger demographic" to continue to seek out "lower cost, apps-based alternatives, with an eye towards free/cheap, but high-demand content".
UAL United Continental
$91.79

-0.81 (-0.87%)

10/30/18
JPMS
10/30/18
DOWNGRADE
Target $95
JPMS
Neutral
United Continental downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jamie Baker downgraded United Continental Holdings to Neutral and lowered his price target for the shares to $95 from $98.
11/12/18
GSCO
11/12/18
INITIATION
Target $102
GSCO
Neutral
United Continental initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Catherine O'Brien started United Continental Holdings with a Neutral rating and $102 price target. The analyst sees relatively lower margin improvement at United versus other airlines. She also launched coverage on the U.S. Airlines sector with an Attractive coverage view. Stronger revenue trends in 2019 coupled with a focus on cost control should drive higher industry operating margins for the first time since 2015 despite fuel headwinds, O'Brien tells investors in a research note.
10/30/18
10/30/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. LabCorp (LH) downgraded to Hold from Buy at Argus with analyst Jasper Hellweg saying the company is faced with pressure from "lower lab testing payment rates mandated by the Protecting Access to Medicaid Act of 2014" along with business disruptions and the impact of acquisitions which resulted in lowers margins for the quarter. 2. E-Trade (ETFC) downgraded to Outperform from Strong Buy at Raymond James with analyst Patrick O'Shaughnessy saying the recent board decision not to sell the business and remain a standalone company takes a sales scenario off the table. The analyst remains positive on shares ans believes there is plenty of upside as management executes on its operating plan. 3. Southwest (LUV) downgraded to Underweight from Neutral at JPMorgan while United Continental (UAL) and Spirit Airlines (SAVE) downgraded to Neutral from Overweight. 4. Flex (FLEX) downgraded to Hold from Buy at Argus with analyst Jim Kelleher citing the expected impact from the "shutdown of Mexican operations with key customer Nike (NKE), which he expects to be fully unwound," as well as the retirement of the company CEO Mike McNamara who had presided over the company's business expansion. 5. Elevate Credit (ELVT) downgraded to Market Perform from Outperform at JMP Securities and William Blair. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/18
JPMS
10/30/18
NO CHANGE
JPMS
JPMorgan downgrades three airlines, upgrades JetBlue to Overweight
JPMorgan analyst Jamie Baker continues to believe that a "trading trifecta" has formed for U.S. Airlines in investors' favor. The case for industry margin expansion remains the best we've seen in four years, and most stocks are within 10% of their autumnal lows, "suggesting seasonal trade-winds may lift equities as they often do," Baker tells investors in a research note. He thinks the industry remains on a path towards margin expansion for the first time since 2014 amid lower year-over-year capacity, "robust" demand, "disciplinary" fuel, and no immediate risk to labor cost assumptions. After making changes to his estimates and price targets, Baker downgraded United Continental (UAL) and Spirit Airlines (SAVE) to Neutral from Overweight, downgraded Southwest Airlines (SAVE) to Underweight from Neutral, and upgraded JetBlue Airways (JBLU) to Overweight from Neutral. Southwest and United entered the year as underperformers, but appear poised to potentially exit as winners, says Baker. From here, he'd rather focus on the "names that haven't worked than pound the table on the two that have." For Southwest, the analyst does not envision significant downside potential, but rather views the stock as "stalled at current valuation levels until such time a trajectory towards higher margins can better be established." Meanwhile, JetBlue is the "cheapest" of the domestic airlines and its target multiple is the lowest, Baker says. He sees over 20% upside potential in the shares.
KO Coca-Cola
$49.77

-0.09 (-0.18%)

11/09/18
BMOC
11/09/18
NO CHANGE
Target $60
BMOC
Outperform
Monster Beverage price target lowered to $60 from $70 at BMO Capital
BMO Capital analyst Amit Sharma lowered his price target on Monster Beverage (MNST) to $60 to reflect its selloff yesterday on reported possibility of Coca-Cola (KO) entering the energy drink category. The analyst notes however that while the threat may pose a near-term overhang on the stock, the impact on its growth and valuation is likely overblown. Sharma cites the "deep economic alignment" between the two companies and their bottlers, along with the company's willingness to find an acceptable resolution. The analyst also keeps his Outperform rating on Monster Beverage.
11/08/18
SUSQ
11/08/18
NO CHANGE
Target $46
SUSQ
Negative
Monster Beverage results solid, but Coke conflict an overhang, says Susquehanna
Susquehanna analyst Pablo Zuanic said Monster Beverage (MNST) reported solid Q3 earnings, though gross margins missed again. However, he thinks a price hike effective on November 1 should mitigate the gross margin pressure. He believes a budding conflict with Coca-Cola (KO) could call into question the company's ability to grow and will be an overhang on the stock. Zuanic reiterated his Negative rating, though he raised his price target to $46 from $44 on Monster Beverage shares.
11/09/18
SBSH
11/09/18
NO CHANGE
Target $56
SBSH
Buy
Coca-Cola should trade at a 50% premium to market, says Citi
After spending time in Europe with CEO James Quincey, Citi analyst Wendy Nicholson says her confidence in Coca-Cola "continues to go up." Given her confidence in the company's ability to deliver on its growth targets, she continues to believe the stock should trade at a 50% premium to the market. The analyst raised her price target for Coca-Cola shares to $56 from $54 and keeps a Buy rating on the name.
11/09/18
GSCO
11/09/18
UPGRADE
Target $66
GSCO
Conviction Buy
Monster Beverage upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman analyst Judy Hong added Monster Beverage to the Conviction Buy List saying concerns over the dispute Coca-Cola (KO) are overdone and recommends buying shares on weakness. Hong believes Monster's shares downside is limited from a Coca-Cola Energy launch and does not believe the partnership is in jeopardy. The analyst sees upside to consensus 2019/20 estimates and a path to her $66 price target based on mid-teens plus earnings growth.
KHC Kraft Heinz
$52.63

-0.75 (-1.41%)

11/05/18
BMOC
11/05/18
NO CHANGE
Target $61
BMOC
Market Perform
Kraft Heinz price target lowered to $61 from $67 at BMO Capital
BMO Capital analyst Kenneth Zaslow lowered his price target on Kraft Heinz to $61 after its Q3 earnings miss, saying the company's "significant operating profit shortfall more than offset better-than-expected top-line growth and a favorable tax rate". The analyst also notes that the management was confident that the company's organic sales growth would persist into Q4 and that its EBITDA growth and margins will recover. Longer term, Zaslow keeps his Market Perform rating on Kraft Heinz based on its "lower EBITDA base and concern that the ongoing transitory issues signify structural and persistent challenge."
11/02/18
JEFF
11/02/18
NO CHANGE
Target $75
JEFF
Buy
Kraft Heinz selloff today a buying opportunity, says Jefferies
Jefferies analyst Akshay Jagdale recommends buying shares of Kraft Heinz on today's post-earnings weakness. The analyst says the quarter delivered on one core pillar of his thesis, which is improvement in organic growth. Kraft Heinz's 2.6% organic growth was the best in at least four years, Jagdale tells investors in a post-earnings research note. However, profitability was much weaker than expected leading to a significant profit miss, says the analyst. He believes the market is viewing this earnings miss as structural while he views it as transitory, "especially in light of the strong sales growth performance and momentum." Jagdale has a Buy rating on Kraft Heinz with a $75 price target. The stock in early trading is down 8%, or $4.40, to $51.80.
11/14/18
JPMS
11/14/18
DOWNGRADE
Target $66
JPMS
Neutral
JPMorgan downgrades Kellogg to Neutral, removes from Analyst Focus List
JPMorgan analyst Ken Goldman downgraded Kellogg (K) to Neutral from Overweight and lowered his price target for the shares to $66 from $73. The analyst also removed the stock from his firm's Analyst Focus List. He says that while nothing at the company's investor day "necessarily disappointed" him, he also did not gain "much comfort that the bottom-line turnaround would be swift." Maintaining an Overweight rating in the face of flat EBIT growth in both 2018 and 2019 "requires a bit more patience than we have at the moment," Goldman writes in a note to investors. With that said, the analyst did raise the likelihood that Kellogg gets taken out at a 25% premium to 15% from 5% in his scenario analysis. This is not because of anything specific to Kellogg, but rather because Kraft Heinz (KHC) seems close to buying something in consumer staples, says the analyst. Goldman sees a number of companies are potential targets, including General Mills (GIS), Kellogg, an overseas food producer, or a consumer staples company outside food.
11/07/18
MSCO
11/07/18
NO CHANGE
Target $49
MSCO
Underweight
Kraft Heinz Canadian cheese divestiture a 'small positive,' says Morgan Stanley
Morgan Stanley analyst Dara Mohsenian called Kraft Heinz's agreement to sell its Canadian natural cheese business to Parmalat for $1.23B a "small positive," stating that the deal removes a less attractive business with a lower margin at a reasonable sales multiple. This second announced small scale divestiture in the last two weeks perhaps highlights the need for Kraft Heinz to prioritize debt pay down, said Mohsenian, who continues to believe the company's balance sheet position is an underappreciated risk. He keeps an Underweight rating on Kraft Heinz shares with a $49 price target.

TODAY'S FREE FLY STORIES

DDAIF

Daimler AG

$0.00

(0.00%)

, FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

08:26
12/15/18
12/15
08:26
12/15/18
08:26
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

F

Ford

$8.53

0.025 (0.29%)

GM

General Motors

$35.10

-0.01 (-0.03%)

HMC

Honda

$26.90

-0.33 (-1.21%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$120.06

-0.83 (-0.69%)

VLKAY

Volkswagen

$0.00

(0.00%)

TSLA

Tesla

$365.69

-11.17 (-2.96%)

LITE

Lumentum

$43.46

-0.4 (-0.91%)

OCLR

Oclaro

$8.27

(0.00%)

FNSR

Finisar

$21.74

-0.4 (-1.81%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

INFN

Infinera

$4.14

-0.095 (-2.25%)

CIEN

Ciena

$34.55

-0.35 (-1.00%)

GOOS

Canada Goose

$52.18

-2.48 (-4.54%)

FDX

FedEx

$184.08

-3.13 (-1.67%)

UPS

UPS

$98.67

-2.1 (-2.08%)

AMZN

Amazon.com

$1,592.14

-67.86 (-4.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

  • 20

    Dec

  • 07

    Jan

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

, RHHBY

Roche

$0.00

(0.00%)

04:55
12/15/18
12/15
04:55
12/15/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO Immuno-Oncology…

BMY

Bristol-Myers

$52.11

-1.54 (-2.87%)

RHHBY

Roche

$0.00

(0.00%)

CELG

Celgene

$68.20

-1.55 (-2.22%)

MRK

Merck

$76.50

-1.94 (-2.47%)

PFE

Pfizer

$43.84

-0.71 (-1.59%)

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

NEO

NeoGenomics

$13.25

-0.18 (-1.34%)

SGEN

Seattle Genetics

$60.46

-0.5 (-0.82%)

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

IMV

IMV Inc

$5.65

-0.14 (-2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 24

    Dec

  • 29

    Dec

  • 11

    Jan

  • 11

    Jan

  • 24

    Jan

  • 16

    Feb

  • 18

    Mar

  • 20

    May

  • 12

    Dec

  • 12

    Dec

TEVA

Teva

$18.46

-0.56 (-2.94%)

18:34
12/14/18
12/14
18:34
12/14/18
18:34
Hot Stocks
Teva, Celltrion announce FDA approval of HERZUMA »

Celltrion and Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVG

Pretium Resources

$7.43

(0.00%)

18:11
12/14/18
12/14
18:11
12/14/18
18:11
Hot Stocks
Pretium Resources: Brucejack approved for production hike to 3,800 tonnes/day »

Pretium Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$15.47

-0.2 (-1.28%)

17:52
12/14/18
12/14
17:52
12/14/18
17:52
Periodicals
FCA says four U.S. plants to have down-time in January, Detroit News says »

Fiat Chrysler said that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNOA

Sonoma Pharmaceuticals

$0.75

-0.0342 (-4.36%)

, CCNI

Command Center

$4.00

-0.075 (-1.84%)

17:43
12/14/18
12/14
17:43
12/14/18
17:43
Hot Stocks
Sonoma Pharmaceuticals CEO Jim Schutz resigns, Frederick Sandford succeeds »

Sonoma Pharmaceuticals…

SNOA

Sonoma Pharmaceuticals

$0.75

-0.0342 (-4.36%)

CCNI

Command Center

$4.00

-0.075 (-1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$62.09

-1.47 (-2.31%)

, XLU

Utilities SPDR

$56.81

-0.13 (-0.23%)

17:38
12/14/18
12/14
17:38
12/14/18
17:38
General news
Week ending ETF scorecard: Energy, Financials lead the decline »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$62.09

-1.47 (-2.31%)

XLU

Utilities SPDR

$56.81

-0.13 (-0.23%)

IYR

DJ US Real Estate Index Fund

$80.37

-0.14 (-0.17%)

XLP

Consumer Staples Sector SPDR

$54.51

-0.97 (-1.75%)

XLY

Consumer Discretionary Sector SPDR

$102.33

-1.75 (-1.68%)

XLB

S&P Select Materials SPDR

$51.37

-0.37 (-0.72%)

XLF

Financial Select Sector

$24.25

-0.24 (-0.98%)

XLV

Health Care Select Sector SPDR

$88.99

-3.05 (-3.31%)

XLK

Technology Select Sector SPDR

$64.58

-1.6 (-2.42%)

XLI

Industrial Select Sector SPDR

$67.06

-0.95 (-1.40%)

GLD

SPDR Gold Shares

$117.10

-0.44 (-0.37%)

SLV

iShares Silver Trust

$13.69

-0.175 (-1.26%)

USO

United States Oil Fund

$10.83

-0.38 (-3.39%)

UNG

United States Natural Gas Fund

$30.78

-2.64 (-7.90%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$83.17

-0.365 (-0.44%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$112.72

-0.125 (-0.11%)

TLT

iShares 20+ Year Treasury Bond Fund

$118.47

0.38 (0.32%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.57

0.19 (0.19%)

SHY

iShares 1-3 Year Treasury Bond

$83.31

0.055 (0.07%)

IWD

iShares Russell 1000 Value

$116.15

-1.71 (-1.45%)

IWF

iShares Russell 1000 Growth

$135.70

-2.96 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEI

Ecology & Environment

$11.50

0.2 (1.77%)

17:35
12/14/18
12/14
17:35
12/14/18
17:35
Hot Stocks
Ecology & Environment receives Nasdaq noncompliance notice »

On December 13, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBC

Luther Burbank

$8.96

-0.045 (-0.50%)

17:34
12/14/18
12/14
17:34
12/14/18
17:34
Hot Stocks
Luther Burbank announces systematic share repurchase plan »

Luther Burbank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYND

MYnd Analytics

$1.33

0.01 (0.76%)

17:31
12/14/18
12/14
17:31
12/14/18
17:31
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RLGT

Radiant Logistics

$4.76

-0.06 (-1.24%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on Radiant Logistics »

Radiant Logistics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALV

KalVista

$22.62

-1.39 (-5.79%)

17:29
12/14/18
12/14
17:29
12/14/18
17:29
Syndicate
Breaking Syndicate news story on KalVista »

KalVista files $200M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

17:25
12/14/18
12/14
17:25
12/14/18
17:25
Hot Stocks
POTUS names Mick Mulvaney acting WH chief of staff »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$260.61

-4.8 (-1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$169.87

-2.585 (-1.50%)

17:20
12/14/18
12/14
17:20
12/14/18
17:20
Hot Stocks
Raytheon awarded $149.44M Navy contract for Standard Missile-2 Block IIIC »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$100.08

-2.73 (-2.66%)

17:15
12/14/18
12/14
17:15
12/14/18
17:15
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNCB

First National Community Bancorp, Inc.

$9.35

0.04 (0.43%)

17:14
12/14/18
12/14
17:14
12/14/18
17:14
Hot Stocks
First National Community Bancorp names R. Gregory Collins as new EVP »

FNCB Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXT

Textron

$49.49

-0.48 (-0.96%)

17:14
12/14/18
12/14
17:14
12/14/18
17:14
Hot Stocks
Textron awarded $314.29M Navy contract modification for LLTM procurement »

Textron has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLDM

Fluidigm

$7.79

-0.39 (-4.77%)

17:14
12/14/18
12/14
17:14
12/14/18
17:14
Hot Stocks
Breaking Hot Stocks news story on Fluidigm »

Levin Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

WTFC

Wintrust Financial

$67.41

-0.88 (-1.29%)

17:06
12/14/18
12/14
17:06
12/14/18
17:06
Hot Stocks
Wintrust Financial acquires Elektra Holding in roughly $51.9M deal »

Wintrust Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$14.51

-0.35 (-2.36%)

17:04
12/14/18
12/14
17:04
12/14/18
17:04
Syndicate
Breaking Syndicate news story on AMC Entertainment »

AMC Entertainment files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$97.19

0.07 (0.07%)

17:03
12/14/18
12/14
17:03
12/14/18
17:03
Hot Stocks
Equifax Canada acquires JLR Inc. »

Equifax Canada announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 18

    Dec

DFS

Discover

$61.83

-1.41 (-2.23%)

17:03
12/14/18
12/14
17:03
12/14/18
17:03
Hot Stocks
Discover executive chairman Nelms to step down effective December 31 »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUTO

AutoWeb

$2.34

-0.01 (-0.43%)

17:00
12/14/18
12/14
17:00
12/14/18
17:00
Hot Stocks
Daniel M. Negari reports 7.1% stake in AutoWeb »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNI

Canadian National

$77.33

-1.39 (-1.77%)

16:46
12/14/18
12/14
16:46
12/14/18
16:46
Hot Stocks
Canadian National, Unifor Local 100 reach tentative agreement »

CN announced that a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSCO

Cisco

$45.80

-1.66 (-3.50%)

16:44
12/14/18
12/14
16:44
12/14/18
16:44
Recommendations
Cisco analyst commentary at Tigress Financial »

Tigress Financial sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 10

    Jan

  • 04

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.